Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5848390 | 0.85 | SPHK1 (0.34) | SPHK1 | |
| SCHEMBL8145278 | 0.84 | SPHK1 (0.35) | SPHK1 | |
| SCHEMBL8112149 | 0.84 | SPHK1 (0.35) | SPHK1 | |
| SCHEMBL5495814 | 0.84 | SPHK1 (0.35) | SPHK1 | |
| SCHEMBL8112146 | 0.84 | SPHK1 (0.35) | SPHK1 | |
| SCHEMBL14750633 | 0.80 | SPHK1 (0.38) | SPHK1 | |
| SCHEMBL8919455 | 0.80 | SPHK1 (0.44) | SPHK1 | |
| SCHEMBL14750600 | 0.74 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL9842063 | 0.73 | KLK7 (0.41) | — | |
| SCHEMBL9841957 | 0.73 | SMN1; SMN2 (0.35) | SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030262-B2 | 3-Amino-2-hydroxyalkanoic acids and their prodrugs | ABBOTT LABORATORIES (US) | 2006-04-18 | — | — | US | disclosed |
| US-20040122098-A1 | 3-Amino-2-hydroxyalkanoic acids and their prodrugs | ABBVIE INC. | 2004-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122098-A1 | 3-Amino-2-hydroxyalkanoic acids and their prodrugs | HDGF, HCAR2, HCAR3 | SPHK1 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.